Why the study?
Does a sequential diagnostic strategy using total creatine kinase and creatine kinase B-subunit accurately diagnose or exclude acute myocardial infarction in suspected patients?
Does a sequential diagnostic strategy using total creatine kinase and creatine kinase B-subunit accurately diagnose or exclude acute myocardial infarction in suspected patients?
Answers are grounded in this paper and cite their sources.
A sequential diagnostic strategy using total creatine kinase and creatine kinase B-subunit provides high sensitivity and posterior probability for diagnosing or excluding acute myocardial infarction.
We evaluated a diagnostic strategy by studying 481 patients suspected of having had an acute myocardial infarction; the prevalence of infarction by independent criteria was 0.43. This strategy is based on the sequential application of: (a) clinical criteria; (b) total creatine kinase determinations in two serum samples drawn within 10 to 20 h of the onset of acute symptoms; and (c) creatine kinase B-subunit (S-CK B) determinations after immunoinhibition with antibodies to creatine kinase M-subunit in the reaction medium in all samples found to have increased total creatine kinase activity. Discrimination limits of 150 U/L total creatine kinase for women and 200 U/L for men gave a diagnostic sensitivity of 0.99. Activities less than these limits in samples identified 68% of the 274 non-infarct cases (posterior probability of a negative result of 0.99) within 20 h. Subsequent determination of S-CK B in 292 patients who were positive by the discrimination limits for total creatine kinase verified myocardial infarction in 99% of 207 cases for which S-CK B exceeded the discrimination limit of 12 U/L. The strategy excluded 98% of all non-infarct cases at a posterior probability of 0.99.
No takes yet. Share an insight, caveat, or question.
Gerhardt et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: